Therefore, the variant classifies as likely pathogenic based on both MHS/RYR1-specific adaptation of the ACMG criteria, and the genetic scoring matrix from The European Malignant Hyperthermia group [24, 25]. This evidence concerns the gene RYR1 and Malignant hyperthermia.